[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100494983":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":35,"locations":42,"responsibleParty":56,"collaborators":26,"id":58,"slug":59,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":26,"eligibilityCriteria":64,"healthyVolunteers":60,"sex":65,"minAge":66,"maxAge":26,"enrollmentInfo":67,"targetDuration":26,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":76,"overallStatus":44,"whyStopped":26,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"National Taiwan University Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Large-area low-level laser therapy","EXPERIMENTAL","Large-area low-level laser therapy(Venusure) was administered at proximal forearm, upper arm and axillary region of affected side. The wavelength was 980±15nm, average dose was 10-40nm\u002Fcm2 and maximal output was 1000mW. Total treatment duration was 30 min and frequency was 3 sessions\u002Fweek for 4 weeks.",[13],"Device: Large-area low-level laser therapy(Venusure)",{"label":15,"type":16,"description":17,"interventionNames":18},"Conventional low-level laser therapy","PLACEBO_COMPARATOR","Conventional low-level laser therapy was administrated on antecubital fossa and the axilla of affected side. The wavelength was 808nm and maximal output was 60 mW. Total treatment duration was 30 min and frequency was 3 sessions\u002Fweek for 4 weeks.",[19],"Device: Conventional low-level laser therapy",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DEVICE","Large-area low-level laser therapy(Venusure)","The wavelength was 980±15nm, average dose was 10-40nm\u002Fcm2 and maximal output was 1000mW. Total treatment duration was 30 min and frequency was 3 sessions\u002Fweek for 4 weeks; for a total of 12 sessions",[9],null,{"type":22,"name":15,"description":28,"armGroupLabels":29,"otherNames":26},"The wavelength was 808 nm and maximal output was 60 mW. Total treatment duration was 30 min and frequency was 3 sessions\u002Fweek for 4 weeks; for a total of 12 sessions.",[15],[31],{"name":32,"affiliation":33,"role":34},"Chueh-Hung Wu, PHD","Department of Physical Medicine and Rehabilitation, National Taiwan University Hospital, Taipei, Taiwan","STUDY_CHAIR",[36],{"name":37,"role":38,"phone":39,"phoneExt":40,"email":41},"Ying-Chun Chen, MD","CONTACT","23123456","55177","yasandy2000@gmail.com",[43],{"facility":5,"status":44,"city":45,"state":26,"zip":26,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"RECRUITING","Taipei","Taiwan","TW",{"type":49,"coordinates":50},"Point",[51,52],121.52639,25.05306,{"lat":52,"lon":51},[55],{"name":37,"role":38,"phone":39,"phoneExt":40,"email":41},{"type":57,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR","100494983","lllt-for-bcrl-a-randomized-placebo-controlled-study-100494983",false,"NCT05725265","LLLT for BCRL: a Randomized, Placebo-controlled Study","Large-area Low-level Laser Therapy for Breast Cancer-related Lymphedema: a Randomized, Placebo-controlled Study","Inclusion Criteria:\n\n* Female subjects, 20 years age or older, suffered from unilateral breast cancer with ipsilateral lumpectomy or mastectomy and lymph node dissection (sentinel biopsy or axillary dissection)\n* Stage I or II unilateral secondary upper extremity lymphedema(as defined by the International Society of Lymphology)\n* Girth≥ 2 cm circumferential difference compared with the uninvolved upper extremity at any 4 cm segment\n* Able to commit to a long-term follow-up schedule\n\nExclusion Criteria:\n\n* Metastatic cancer(stage IV)\n* Pregnancy\n* Presence of other extremity lymphedema (primary or secondary)\n* History of deep vein thrombosis\n* Pacemaker\n* Artificial joints, implant or tattoo(area≥4 cm2) at the involved upper extremity\n* Previous treatment with low-level laser therapy (within 3 months)\n* Body mass index (BMI) \\> 35 (morbid obesity)\n* High bleeding tendency(hemophilia)\n* Receiving long-term steroid treatment (oral or systemic)","FEMALE","20 Years",{"count":68,"type":69},54,"ESTIMATED","INTERVENTIONAL",[72],"NA","This study is conducted to compare between efficacy of large and small area of low-level laser therapy (LLLT) in treatment of post mastectomy lymphedema. The change of severity of BCRL will be measured by the difference of circumference and skin thickness, detected by ultrasound. The influence on clinical symptoms, such as pain, shoulder mobility and hand function, are also investigated in the study.",[75],"Breast Cancer Lymphedema",[75,77,78,79],"Lymphedema","Breast cancer","Low level laser therapy","2024-10-16",{"date":82,"type":83},"2024-10-18","ACTUAL",{"date":85,"type":83},"2023-10-24",{"date":87,"type":69},"2025-10-31",{"name":5,"class":6},1]